Related Experiment Video
Updated: Feb 18, 2026

Innovative Strategies for Organ Preservation in Heart Transplantation: Uniform Cooling Preservation and Ex-situ Normothermic Perfusion
Published on: November 28, 2025
Renal protection strategies after heart transplantation
Daniel Reichart1, Hermann Reichenspurner1, Markus Johannes Barten1
1Department of Cardiovascular Surgery, , University Heart Center Hamburg, Hamburg, Germany.
Abstract:
Renal dysfunction caused by calcineurin inhibitor (CNI) nephrotoxicity occurs often and contributes significantly to late mortality after heart transplantation (HTx). Over the last decades, this has prompted many clinical studies in an effort to develop kidney-protecting immunosuppressive strategies including delayed CNI start, minimization, withdrawal, or even de novo CNI avoidance. In the past, these strategies often failed due to the lack of efficacy. Since 2009, novel CNI-reducing strategies have been under investigation. These strategies minimize renal damage using induction agents such as antithymocyte globulin and alternative immunosuppressive agents such as the mechanistic target of rapamycin inhibitors (sirolimus or everolimus) or mycophenolate. This review outlines the recent results of using these renal protection strategies including their drawbacks. We also discuss alternative approaches to optimize individual immunosuppressive therapies after HTx.
Insights
Calcineurin inhibitor (CNI) nephrotoxicity is a major cause of kidney dysfunction after heart transplantation. Novel CNI-reducing strategies show promise in minimizing renal damage and improving outcomes.
Area of Science:
- Nephrology
- Immunology
- Cardiology
Background:
- Calcineurin inhibitor (CNI) nephrotoxicity frequently causes renal dysfunction and mortality post-heart transplantation (HTx).
- Previous kidney-protecting strategies like CNI minimization or withdrawal often lacked efficacy.
Purpose of the Study:
- To review recent renal protection strategies in heart transplant recipients.
- To discuss the efficacy, drawbacks, and optimization of immunosuppressive therapies.
Main Methods:
- Review of clinical studies investigating novel CNI-reducing immunosuppressive strategies since 2009.
- Analysis of agents like antithymocyte globulin, sirolimus, everolimus, and mycophenolate.
Main Results:
- Novel CNI-reducing strategies, utilizing induction agents and alternative immunosuppressants, aim to minimize renal damage.
- These newer approaches are under investigation for their effectiveness and safety profiles.
Conclusions:
- Optimizing immunosuppressive therapy is crucial for reducing CNI nephrotoxicity after heart transplantation.
- Individualized approaches are needed to balance immunosuppression efficacy with renal protection.
Related Concept Videos
Kidney Transplant III: Nursing Management
Kidney Transplant II: Surgical Procedure
Kidney Transplant I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury V: Interprofessional Care
Continuous Renal Replacement Therapy

